Phibro Animal Health (PAHC) Goodwill & Intangibles (2013 - 2026)
Phibro Animal Health's (PAHC) quarterly Goodwill & Intangibles came in at $91.6 million in Q1 2026, down 0.83% year-on-year from $92.3 million in Q1 2025, and down 1.41% quarter-over-quarter from $92.9 million in Q4 2025.
Phibro Animal Health (PAHC) Goodwill & Intangibles (2013 - 2026) Analysis & Trends
Phibro Animal Health's Goodwill & Intangibles history runs 14 years deep, the most recent figure standing at $91.6 million for Q1 2026.
- On a quarterly basis, Goodwill & Intangibles fell 0.83% year-over-year to $91.6 million in Q1 2026; TTM through Mar 2026 was $91.6 million, a 0.83% decrease from a year earlier, with the FY2025 full-year figure at $96.1 million, down 3.49% from the prior year.
- Goodwill & Intangibles fell to $91.6 million in Q1 2026 per PAHC's latest filing, from $92.9 million in the prior quarter.
- Across five years, Goodwill & Intangibles topped out at $203.2 million in Q2 2023 and bottomed at $68.0 million in Q1 2022.
- The 5-year median for Goodwill & Intangibles is $99.6 million (2024), against an average of $105.8 million.
- Across the five-year window, Goodwill & Intangibles surged 73.59% in 2023 and tumbled 51.0% in 2024, its largest moves.
- Year by year, Goodwill & Intangibles stood at $112.3 million in 2022, then dropped by 5.92% to $105.6 million in 2023, then retreated by 10.6% to $94.4 million in 2024, then slipped by 1.65% to $92.9 million in 2025, then retreated by 1.41% to $91.6 million in 2026.
- Per Business Quant, the three latest PAHC Goodwill & Intangibles figures stand at $91.6 million (Q1 2026), $92.9 million (Q4 2025), and $94.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn |
| 10 | Phibro Animal Health | 1.43 Bn | 1.35 Bn | 125.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.57 Mn |
| Dec 31, 2025 | 92.88 Mn |
| Sep 30, 2025 | 94.67 Mn |
| Jun 30, 2025 | 96.11 Mn |
| Mar 31, 2025 | 92.34 Mn |
| Dec 31, 2024 | 94.44 Mn |
| Sep 30, 2024 | 97.52 Mn |
| Jun 30, 2024 | 99.59 Mn |
| Mar 31, 2024 | 102.88 Mn |
| Dec 31, 2023 | 105.65 Mn |
| Sep 30, 2023 | 105.44 Mn |
| Jun 30, 2023 | 203.25 Mn |
| Mar 31, 2023 | 110.14 Mn |
| Dec 31, 2022 | 112.29 Mn |
| Sep 30, 2022 | 114.34 Mn |
| Jun 30, 2022 | 117.09 Mn |
| Mar 31, 2022 | 67.98 Mn |
| Dec 31, 2021 | 110.65 Mn |
| Sep 30, 2021 | 112.80 Mn |
| Jun 30, 2021 | 114.96 Mn |